- A coronavirus vaccine developed by the University of Oxford stops 70% of people from developing symptoms, a large scale trial shows
- It is both a triumph and a disappointment after other vaccines showed 95% protection
- But the Oxford jab is much cheaper, and easier to store and distribute widely than the other two
- Boris Johnson praised scientists and volunteers for the trial's "fantastic results"
- The UK prime minister will later explain the detail of England's return to the "three tier system" when lockdown ends on 2 December
- Parts of the system will be tougher, but gyms and shops will reopen and a closing time curfew for pubs and restaurants will be eased
- UK-wide coronavirus rules on gatherings and travel over Christmas are still yet to be confirmed
- Meanwhile, Germany's chancellor Angela Merkel has raised concerns about the world's poorest securing access to Covid-19 vaccines
- There have been more than 58.6m virus cases and 1.3m Covid-19 deaths across the globe, according to data from Johns Hopkins University
Hello and welcome to our live coverage of the coronavirus pandemic. Here’s a quick update of the main stories from the UK this morning:
- Prime Minister Boris Johnson has described the results from the Oxford Covid vaccine trial as "fantastic" and "incredibly exciting". The vaccine stops 70% of people developing Covid symptoms, a large-scale trial shows
- Gyms and non-essential shops in all areas are expected to be allowed to reopen when England's lockdown ends on 2 December
- While parts of the country’s three-tier system will be toughened, the 10pm closing time for pubs and restaurants will be relaxed
- A ban on outdoor grassroots sports in England is also set to be lifted
- Johnson will explain the detail of England's return to the "three tier system" in a statement later
- Chancellor Rishi Sunak has said people "will not see austerity" when he makes spending announcements for public services this week, despite the billions spent on the pandemic response
- Train companies are extending a scheme offering free travel to those fleeing domestic abuse in Great Britain until the end of March next year
Oxford vaccine both a triumph and a disappointmentJames Gallagher - Health and science correspondent, BBC News
The vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large-scale trial has shown.
It is both a triumph and a disappointment after vaccines by Pfizer and Moderna showed 95% protection.
However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two - so it will still play a significant role in tackling the pandemic, if it is approved by regulators.
There is also intriguing data that suggests perfecting the dose could increase protection up to 90%.
Read more from James here .
Key global developments from the last few hours:
- Global cases approach 60m. The global coronavirus infections total is currently 58,563,451, according to the Johns Hopkins University tracker – less than 2.5m cases from 60m.With daily totals averaging at around 600,000, the global infections total is likely to pass 60m this week – just under three weeks after it passed 50m.The global death toll is nearing 1.4m people. It currently stands at 1,386,465.
- Chaos at Shanghai airport after sudden decision to test thousands - reports. The Global Times reports that Shanghai Pudong airport has started testing thousands of staff and passengers after several cargo handlers tested positive for coronavirus. Hundreds of flights have also been cancelled, and videos posted online appear to show people panicking as they are told they will all be tested for the virus.
- South Korea reported another daily rise of over 200 new coronavirus cases on Monday, a day before tighter social distancing rules aimed at blunting a third wave of infections take effect. The daily tally of 271 new cases fell from 330 reported on Sunday after hovering above 300 for five straight days, a level not seen since August, according to the Korea Disease Control and Prevention Agency.
- Hong Kong-Singapore travel bubble pops. The much-hyped Hong Kong-Singapore travel bubble has postponed, one day before the first flights were set to depart. The bubble was postponed after Hong Kong health authorities reported a rise in new cases, including 43 on Saturday alone, 13 of which were untraced local infections.The bubble allows people to travel between Singapore and Hong Kong for leisure, and to take a Covid test in lieu of quarantine or home isolation.
- US suffers one Covid death every minute. In the US, 1,448 people died on Friday according to Johns Hopkins University – the equivalent of a person every minute, as Bloomberg’s Steven Dennis pointed out on Twitter on Sunday.
- UK government to ease isolation requirements for Covid contacts. The UK government will announce on Monday that self-isolation will no longer be required for those who have come into contact with people who have tested positive for Covid-19, the Telegraph reported. Contacts of those who test positive will be asked to undergo daily tests for seven days, and will be allowed to go about their business in the meantime, the newspaper said.
- The first Americans could be vaccinated on 11 December. US Covid-19 vaccine programme head Moncef Slaoui said the first Americans to receive a coronavirus vaccine could get it as soon as 11 December, CNN reported on Sunday.“Our plan is to be able to ship vaccines to the immunisation sites within 24 hours from the approval, so I expect maybe on day two after approval on the 11 or the 12 of December,” he said in an interview to CNN.
- Germany may start Covid-19 vaccine programme in December. Germany could start administering shots of Covid-19 vaccines as soon as next month, health minister Jens Spahn was quoted as saying. “There is reason to be optimistic that there will be approval for a vaccine in Europe this year,” Spahn said in an interview with publishing group RedaktionsNetzwerk Deutschland. “And then we can start right away.”
- NHS told to be ready to administer vaccine by 1 December. Britain could give regulatory approval to Pfizer-BioNTech’s Covid-19 vaccine this week, even before the US authorises it, the Telegraph news site reported on Sunday.Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by 1 December. The US Food and Drug Administration said on Friday that it would meet on 10 December to discuss whether to authorise the vaccine.
- Spain to begin vaccinations in January. Spain will begin a comprehensive coronavirus vaccination programme in January and expects to have covered a substantial part of the population within three months, Prime Minister Pedro Sanchez said on Sunday. He said Spain and Germany were the first European Union countries to have a complete vaccination plan in place.
- Experts have urged Americans against travelling for family gatherings at Thanksgiving this week even though millions were set to defy the advice , as the US crossed the threshold of more than 12m cases of coronavirus.Ominous warnings came as Donald Trump appeared to admit that coronavirus is “running wild” across the US, in contrast with his statements throughout the election campaign that the virus would simply “go away” or “disappear” and, more recently, that the country was “rounding the turn” on the pandemic.